SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths - 2How color-changing, bacteria-infused spacesuits could help keep future astronauts safe from space radiation
- 3UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
- 4General Atlantic says ‘biggest mistake’ would be pulling back on Gulf deals
- 5Supportive Tips On Home loans For First-Time Home Purchasers
- Artemis II astronauts make long-distance call to the space station as they head home from the moon
- Understanding Preschool Projects: Cultivating Abilities and Advancement
- Tickets for 'Stranger Things' Season 5 finale, to be shown in movie theaters on New Year's Eve, go on sale today. Here's how you can save your seat.
- Instructions to Pick the Ideal Pre-assembled Home for Your Necessities
- Passover under fire: Israelis balance fatigue with cautious hope after month of war
- China resumes flights to North Korea after a six-year pause
- The most effective method to Beat Dental Tension and Guarantee Customary Exams
- Instructions to Clean and Really focus on Your Lab Precious stone
- The most effective method to Succeed in Your Web based Advertising Degree: Procedures for Progress
